Cardiac sympathetic nervous disintegrity is related to exercise intolerance in patients with chronic heart failure
- PMID: 9853334
- DOI: 10.1097/00006231-199805000-00007
Cardiac sympathetic nervous disintegrity is related to exercise intolerance in patients with chronic heart failure
Abstract
The aim of this study was to clarify the relationship between cardiac sympathetic nervous activity assessed by 123I-MIBG imaging and exercise capacity in patients with congestive heart failure. The subjects were 24 patients with heart failure (NYHA class II to III) and 7 normal controls. A dose of 148 MBq of 123I-MIBG was administered intravenously, and 5-min anterior planar images were obtained 20 min (early) and 4 h (delayed) after the injection of 123I-MIBG. Regions of interest were placed over the left ventricle and mediastinum, and the heart-to-mediastinum ratio (H/M ratio) was calculated as a fraction of the mean counts per pixel in the heart divided by those in the mediastinum. The washout rate from the myocardium was determined by: (early counts delayed counts) x 100/early counts (%). Treadmill exercise tests were performed using a ramp method within 1 week of the 123I-MIBG studies. During exercise, expired gas was analysed, and peak VO2 and VO2 at the anaerobic threshold (ATVO2) were measured. A significant linear correlation was found between the H/M ratio on delayed 123I-MIBG images and exercise duration (r = 0.48, P < 0.05), peak VO2 (r = 0.49, P < 0.05) and ATVO2 (r = 0.56, P < 0.01). The washout rate of 123I-MIBG was inversely correlated with exercise duration (r = -0.45, P < 0.05), peak VO2 (r = -0.51, P < 0.01), and ATVO2 (r = -0.50, P < 0.05). In conclusion, enhanced cardiac sympathetic nervous activity relates to exercise intolerance in patients with congestive heart failure. The non-invasive assessment of cardiac sympathetic nervous activity by 123I-MIBG can predict exercise capacity in human heart failure.
Similar articles
-
Ongoing myocardial damage relates to cardiac sympathetic nervous disintegrity in patients with heart failure.Ann Nucl Med. 2005 Oct;19(7):535-40. doi: 10.1007/BF02985045. Ann Nucl Med. 2005. PMID: 16363617 Clinical Trial.
-
Clinical relationship of myocardial sympathetic nervous activity to cardiovascular functions in chronic heart failure: assessment by myocardial scintigraphy with 123I-metaiodobenzylguanidine.Tohoku J Exp Med. 2003 Dec;201(4):261-70. doi: 10.1620/tjem.201.261. Tohoku J Exp Med. 2003. PMID: 14690018
-
[Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].Rinsho Shinkeigaku. 2003 Aug;43(8):465-9. Rinsho Shinkeigaku. 2003. PMID: 14658397 Clinical Trial. Japanese.
-
Variation of heart-to-mediastinal ratio in (123)I-mIBG cardiac sympathetic imaging: its affecting factors and potential corrections.Curr Cardiol Rep. 2011 Apr;13(2):132-7. doi: 10.1007/s11886-010-0157-y. Curr Cardiol Rep. 2011. PMID: 21221858 Review.
-
123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation.Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):813-824. doi: 10.1007/s00259-022-05941-3. Epub 2022 Sep 8. Eur J Nucl Med Mol Imaging. 2023. PMID: 36071220 Free PMC article. Review.
Cited by
-
Prognostic effect and modulation of cardiac sympathetic function in heart failure patients treated with cardiac resynchronization therapy.J Nucl Cardiol. 2020 Feb;27(1):283-290. doi: 10.1007/s12350-018-1357-x. Epub 2018 Jul 10. J Nucl Cardiol. 2020. PMID: 29992524 Clinical Trial.
-
Resting muscle sympathetic nerve activity, cardiac metaiodobenzylguanidine uptake, and exercise tolerance in patients with left ventricular dysfunction.J Nucl Cardiol. 2009 Mar-Apr;16(2):244-50. doi: 10.1007/s12350-008-9039-8. Epub 2009 Jan 22. J Nucl Cardiol. 2009. PMID: 19159993
-
Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy.Eur J Nucl Med Mol Imaging. 2005 Feb;32(2):221-8. doi: 10.1007/s00259-004-1663-1. Epub 2004 Sep 23. Eur J Nucl Med Mol Imaging. 2005. PMID: 15449048 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical